Vidac Pharma | Oncology | Novel Therapeutics | Business Coaching | Business Development
The VIDAC-team is developing novel cancer therapeutics. The core innovation is to reverse the Warburg effect of cancer cells, as they produce energy through glycolysis despite the presence of oxygen. VIDAC disables the anchoring of HK2 to the VDAC pores. Hereby, the cancer cell metabolism now reverses towards the normal-cell state. The outcome: Inhibition of tumor hyper growth, reactivation of the immune response, and stopping cancer proliferation.
The management team chose me as EIC-sponsored Business Coach focused on enhancing the explanation and communication of the VIDAC innovation and its expected impact.
I reviewed all prior presentations and grant application materials.
In a series of sessions we collaborated on describing and communicating the core of the VIDAC innovation and the profound impact it will have for oncologists and patients.
Testimonial from Vidac Pharma is available.